A groundbreaking study conducted by Israeli scientists has revealed a novel approach to deep brain stimulation (DBS) that shows promise in alleviating symptoms of schizophrenia. The research, published in Nature Communications, suggests that targeted DBS can potentially restore cognitive functions often impaired by the chronic mental disorder, offering a new avenue of hope for individuals who don’t respond adequately to existing treatments.
Schizophrenia affects approximately one in 143 people in Israel, impacting roughly 70,000 individuals, according to Ozma, an Israeli mental health organization. The condition is characterized by a range of symptoms, but often includes difficulties with movement, learning, and decision-making. This new research focuses on addressing the underlying neurological mechanisms contributing to these challenges, rather than solely managing the symptoms themselves.
Dr. Nir Asch, a physician and researcher at Rambam Health Care Campus in Haifa, led the peer-reviewed study. He explained that the research provides “a clear theory about what is happening on a mechanical level in the brain, and too a way to solve it.” The team leveraged computational modeling, data analysis, and machine learning to pinpoint specific brain targets for stimulation. The work was conducted under the guidance of Prof. Hagai Bergman, a neuroscientist from the Hebrew University of Jerusalem and a pioneer in DBS, initially developed for Parkinson’s disease.
Understanding the Brain’s Role in Schizophrenia
Traditional approaches to understanding schizophrenia have largely focused on defining the illness by its symptoms. This research, however, delves deeper, attempting to identify the specific neurological processes that are disrupted. Researchers have been exploring the role of the basal ganglia-dorsolateral prefrontal cortex (BG-DLPFC) network in cognitive flexibility and learning. A study published in PubMed in May 2025, found that imbalances within this network may contribute to the cognitive challenges experienced by individuals with schizophrenia. Read more about the study here.
The study in Nature Communications builds on this understanding, suggesting that stimulating the external segment of the globus pallidus (GPe), a central nucleus within the BG network, can help restore balance to these disrupted processes. Researchers found that in nonhuman primates, low-frequency GPe macro-stimulation restored a balance of exploration types disrupted by a PCP-induced model of schizophrenia. This suggests a potential pathway for restoring cognitive flexibility in humans.
Deep Brain Stimulation: A Potential New Therapy
Deep brain stimulation involves surgically implanting electrodes in specific areas of the brain and delivering electrical impulses. While already an established treatment for conditions like Parkinson’s disease, its application to psychiatric disorders is still relatively new. The Israeli researchers believe this targeted approach could offer a significant benefit to patients who have not responded to conventional treatments, such as medication and therapy.
Researchers at Rambam Medical Center’s psychiatric department announced the development of this new DBS approach on February 1, 2026. More details can be found here. The Times of Israel reported that Dr. Asch emphasized the potential for this therapy to “expand the treatment options for patients with schizophrenia.”
Looking Ahead
While these findings are promising, it’s important to note that this research is still in its early stages. Further studies are needed to confirm the efficacy and safety of this DBS approach in humans. Researchers are also working to refine the targeting of stimulation and personalize treatment plans based on individual patient needs. The team hopes to eventually translate these findings into a widely available therapeutic option for individuals struggling with treatment-resistant schizophrenia.
The development of this new therapy represents a significant step forward in our understanding and treatment of schizophrenia. As research continues, there is growing optimism that DBS could offer a life-changing intervention for those who have not found relief through traditional methods.
What are your thoughts on this new approach to treating schizophrenia? Share your comments below, and please share this article with anyone who might find it informative.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
